{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:37:44Z","timestamp":1773149864705,"version":"3.50.1"},"reference-count":27,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2024]]},"DOI":"10.3960\/jslrt.24050","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T22:15:59Z","timestamp":1732745759000},"page":"318-322","source":"Crossref","is-referenced-by-count":2,"title":["Discrepancy of Hans\u2019 criteria for clonally related nodal and pericardiac fluid diffuse large B-cell lymphoma with &lt;i&gt;MYD88&lt;\/i&gt; L265P mutation"],"prefix":"10.3960","volume":"64","author":[{"given":"Toshiki","family":"Terao","sequence":"first","affiliation":[{"name":"Department of Hematology, NHO Iwakuni Clinical Center, Iwakuni, Japan,"},{"name":"Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Medical School, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pathology, NHO Iwakuni Clinical Center, Iwakuni, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, NHO Hiroshimanishi Medical Center, Hiroshima, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoka","family":"Haratake","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori Filiz","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Kuyama","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, NHO Iwakuni Clinical Center, Iwakuni, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Alaggio R, Amador C, Anagnostopoulos I, <i>et al.<\/i> The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid neoplasms. Leukemia. 2022; 36: 1720-1748.","DOI":"10.1038\/s41375-022-01620-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Alexanian S, Said J, Lones M, Pullarkat ST. KSHV\/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states. Am J Surg Pathol. 2013; 37: 241-249.","DOI":"10.1097\/PAS.0b013e318267fabc"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kaji D, Ota Y, Sato Y <i>et al.<\/i> Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis. Blood Adv. 2020; 4: 4442-4450.","DOI":"10.1182\/bloodadvances.2020002293"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Terasaki Y, Yamamoto H, Kiyokawa H <i>et al.<\/i> Disappearance of malignant cells by effusion drainage alone in two patients with HHV-8-unrelated HIV-negative primary effusion lymphoma-like lymphoma. Int J Hematol. 2011; 94: 279-284.","DOI":"10.1007\/s12185-011-0906-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Zaimoku Y, Takahashi W, Iwaki N <i>et al.<\/i> Human herpesvirus-8-unrelated primary effusion lymphoma of the elderly not associated with an increased serum lactate dehydrogenase level: A benign sub-group of effusion lymphoma without chemotherapy. Leuk Lymphoma. 2016; 57: 1625-1632.","DOI":"10.3109\/10428194.2015.1088649"},{"key":"6","unstructured":"6 Das DK, Gupta SK, Ayyagari S <i>et al.<\/i> Pleural effusions in non-Hodgkin\u2019s lymphoma. A cytomorphologic, cytochemical and immunologic study. Acta Cytol. 1987; 31: 119-124."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Das DK. Serous effusions in malignant lymphomas: a review. Diagn Cytopathol. 2006; 34: 335-347.","DOI":"10.1002\/dc.20432"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Hans CP, Weisenburger DD, Greiner TC <i>et al.<\/i> Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004; 103: 275-282.","DOI":"10.1182\/blood-2003-05-1545"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Guti\u00e9rrez-Garc\u00eda G, Cardesa-Salzmann T, Climent F <i>et al.<\/i> Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Blood. 2011; 117: 4836-4843.","DOI":"10.1182\/blood-2010-12-322362"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Abdulla M, Hollander P, Pandzic T <i>et al.<\/i> Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma. Am J Hematol. 2020; 95: 57-67.","DOI":"10.1002\/ajh.25666"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Siddiqi IN, Shibata D. Diffuse large B-cell lymphoma of germinal center and nongerminal center phenotypes presenting concurrently at the same anatomic site: intratumoral heterogeneity or composite lymphoma? Appl Immunohistochem Mol Morphol. 2015; 23: 78-80.","DOI":"10.1097\/PAI.0000000000000027"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Sugitani A, Fukuhara S, Shibata M <i>et al.<\/i> Diffuse large B-cell lymphoma with composite germinal center and non-germinal center types: A report of two cases. J Clin Exp Hematop. 2023; 63: 181-186.","DOI":"10.3960\/jslrt.23020"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Wu W, Youm W, Rezk SA, Zhao X. Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of 54 cases in the literature. Am J Clin Pathol. 2013; 140: 258-273.","DOI":"10.1309\/AJCPHZ3CHO4HUWET"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Choi WW, Weisenburger DD, Greiner TC <i>et al.<\/i> A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res. 2009; 15: 5494-5502.","DOI":"10.1158\/1078-0432.CCR-09-0113"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Gruchy JR, Barnes PJ, Dakin Hach\u00e9 KA. CytoLyt\u00ae fixation and decalcification pretreatments alter antigenicity in normal tissues compared with standard formalin fixation. Appl Immunohistochem Mol Morphol. 2015; 23: 297-302.","DOI":"10.1097\/PAI.0000000000000082"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Sauter JL, Grogg KL, Vrana JA <i>et al.<\/i> Young investigator challenge: Validation and optimization of immunohistochemistry protocols for use on cellient cell block specimens. Cancer Cytopathol. 2016; 124: 89-100.","DOI":"10.1002\/cncy.21660"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Buonocore DJ, Konno F, Jungbluth AA <i>et al.<\/i> CytoLyt fixation significantly inhibits MIB1 immunoreactivity whereas alternative Ki-67 clone 30-9 is not susceptible to the inhibition: critical diagnostic implications. Cancer Cytopathol. 2019; 127: 643-649.","DOI":"10.1002\/cncy.22170"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Silkenstedt E, Salles G, Campo E, Dreyling M. B-cell non-Hodgkin lymphomas. Lancet. 2024; 403: 1791-1807.","DOI":"10.1016\/S0140-6736(23)02705-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Tilly H, Morschhauser F, Sehn LH <i>et al.<\/i> Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma. N Engl J Med. 2022; 386: 351-363.","DOI":"10.1056\/NEJMoa2115304"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Wilson WH, Wright GW, Huang DW, <i>et al.<\/i> Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL. Cancer Cell. 2021; 39: 1643-1653. e3.","DOI":"10.1016\/j.ccell.2021.10.006"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Zhang MC, Tian S, Fu D, <i>et al.<\/i> Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial. Cancer Cell. 2023; 41: 1705-1716. e5.","DOI":"10.1016\/j.ccell.2023.09.004"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Frauenfeld L, Castrejon-de-Anta N, Ramis-Zaldivar JE <i>et al.<\/i> Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements. Blood Adv. 2022; 6: 2361-2372.","DOI":"10.1182\/bloodadvances.2021006034"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Schmitz R, Wright GW, Huang DW <i>et al.<\/i> Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med. 2018; 378: 1396-1407.","DOI":"10.1056\/NEJMoa1801445"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Maeshima AM, Taniguchi H, Takahashi Y <i>et al.<\/i> Heterogeneity or change in cell of origin in diffuse large B-cell lymphomas determined using hans algorithm. Hum Pathol. 2024; 151: 105630.","DOI":"10.1016\/j.humpath.2024.105630"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Roider T, Seufert J, Uvarovskii A <i>et al.<\/i> Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels. Nat Cell Biol. 2020; 22: 896-906.","DOI":"10.1038\/s41556-020-0532-x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Sangaletti S, Iannelli F, Zanardi F <i>et al.<\/i> Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces. EBioMedicine. 2020; 61: 103055.","DOI":"10.1016\/j.ebiom.2020.103055"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Ye X, Wang L, Nie M <i>et al.<\/i> A single-cell atlas of diffuse large B cell lymphoma. Cell Rep. 2022; 39: 110713.","DOI":"10.1016\/j.celrep.2022.110713"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/4\/64_24050\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T05:04:13Z","timestamp":1735362253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/4\/64_24050\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.24050","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"24050"}}